Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Spitz

Showing results (601-610 of 808) with videos related to

Pageof 81
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysisKristina R Dahlstrom, Karen Adler-Storthz, Carol J Etzel, et al.
International Journal of Cancer|February 3, 2005
Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysisAna S Neumann, Heather J Lyons, Hongbing Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapyJoe Y Chang, Ritsuko Komaki, Ryohei Sasaki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Carcinogenesis|May 1, 1995
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase thetaH H Nelson, J K Wiencke, D C Christiani, et al.
Free Radical Biology & Medicine|November 6, 2008
Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanismDavid M Mattson, Iman M Ahmad, Disha Dayal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 1998
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancerQ Wei, S A Eicher, Y Guan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanomaI Bedrosian, A M Scheff, R Mick, et al.
Pageof 81

Showing results (601-610 of 808) with videos related to

Sort By:
Pageof 81
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2003
Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysisKristina R Dahlstrom, Karen Adler-Storthz, Carol J Etzel, et al.
International Journal of Cancer|February 3, 2005
Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysisAna S Neumann, Heather J Lyons, Hongbing Shen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2007
Identification of high-risk patients among those diagnosed with thin cutaneous melanomasPhyllis A Gimotty, David E Elder, Douglas L Fraker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2005
High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapyJoe Y Chang, Ritsuko Komaki, Ryohei Sasaki, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 5, 2011
Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patientsJ Jack Lee, Xifeng Wu, Michelle A T Hildebrandt, et al.
Cancer|October 24, 2006
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanomaLaura L Kruper, Francis R Spitz, Brian J Czerniecki, et al.
Carcinogenesis|May 1, 1995
Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase thetaH H Nelson, J K Wiencke, D C Christiani, et al.
Free Radical Biology & Medicine|November 6, 2008
Cisplatin combined with zidovudine enhances cytotoxicity and oxidative stress in human head and neck cancer cells via a thiol-dependent mechanismDavid M Mattson, Iman M Ahmad, Disha Dayal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 6, 1998
Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancerQ Wei, S A Eicher, Y Guan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 15, 1999
99mTc-human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanomaI Bedrosian, A M Scheff, R Mick, et al.
Pageof 81